CompletedNot Applicable

Study on Infectious Mononucleosis in Munich

Germany200 participantsStarted 2016-03-01

Plain-language summary

This observational clinical study aims at the identification of novel biomarkers and causative factors of complicated and/or protracted Epstein-Barr virus-associated infectious mononucleosis (IM). Clinical, biochemical, and routine virological data were collected from 200 patients with IM, novel analytical tools were implemented, and immunological and virological experimental data were generated using blood samples and mouthwashes. Patients have been investigated within four weeks after the onset of symptoms as well as one month and six months thereafter.

Who can participate

Age range0 Years – 39 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * IM onset within the last four weeks * with at least one of four typical clinical findings (tonsillopharyngitis, fever, lymphadenopathy, fatigue) - virological findings indicating primary EBV infection (EBV-specific antibodies, EBV DNA). Exclusion Criteria: * Pregnancy * transfusion * and/or transplantation during the last year * and/or no informed consent.

What they're measuring

Severity

Timeframe: Six months

Complexity

Timeframe: Six months

Protraction

Timeframe: Six months

Trial details

NCT IDNCT06002802

SponsorTechnical University of Munich

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-08-31

View on ClinicalTrials.gov More Infectious Mononucleosis trials